Complete Structure of p53 Protein Revealed

The tumor suppressor protein p53 is often called “the guardian of the genome” as it helps protect DNA from stress and damage. However, mutations in the p53 gene that encodes this protein can prevent it from functioning correctly, accumulating genetic errors and diseases such as cancer. A recent breakthrough in cancer research has shed new light on the structure and function of the p53 protein and how mutations in it can affect different types of cancer.

A team of researchers led by Penn State University used patient samples to uncover the complete structure of the p53 protein, providing valuable insights into the 3D arrangements that can inform new therapeutic approaches. Previous studies had identified p53 as a critical focal point in the development of tumors, but without a complete understanding of its structure, it was challenging to develop effective treatments for diseased cells.

Using cryo-electron microscopy, the researchers imaged individual p53 proteins isolated from brain tumor cells. They used silicon-based microchips to capture the proteins in a way that allowed them to resolve previously unseen molecular features. This technique revealed that the p53 protein comprises individual units called monomers that combine to create larger entities known as dimers and tetramers.

The researchers found that different forms of p53, such as monomers, dimers, and tetramers, serve different purposes based on events inside the cell’s nucleus. They also discovered a “closed” molecule configuration, which acts like being at the starting blocks before a race, primed and ready to run toward DNA when other cellular signals indicate problems.

Mutations in the p53 gene can lead to p53 proteins that cannot communicate effectively with other cellular components. The researchers used molecular modeling software to simulate changes in the p53 monomer structure and identified seven “hotspots” where mutations in the protein structure are most commonly linked to cancer. These mutations typically lead to less favorable patient outcomes in terms of disease progression and chemoresistance.

The researchers found that slight shifts in the 3D structure of a mutated p53 can affect the protein’s surface charges, which work to repel and attract charges of other molecular units. This can impede proper interactions between the protein and DNA, leading to a breakdown in p53’s ability to assist with regulatory or repair processes essential for maintaining healthy cells.

This new understanding of p53’s complete structure and how mutations can affect different types of cancer opens up new avenues for research into more targeted and effective cancer treatments. The team is also exploring new therapeutic approaches based on their new understanding of p53’s full 3D structure. This breakthrough will lead to more personalized cancer treatments and a better understanding of the role of p53 in the development and progression of different types of cancer.